ATM and prostate carcinoma: Various testing panels assess many germline mutations, but we will consider the main elevation in prostate cancer risk to occur among individuals with germline mutations in (1) BRCA 1, (2) BRCA 2, (3) ATM, (4) CHECK 2, and (5) HOX B13.